BRD-K00384875-001-01-3 (Substance)

Compound:

4-[[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-9-[(1-oxo-2-phenylethyl)amino]-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzoic acid

Compound (Entity type)

Synonyms:BRD-K00384875-001-01-3

Id:85798200

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-K00384875-001-01-3's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 PAC011 U2OS 6H F08 BRD-K00384875 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.L10 24H D24 BRD-K00384875 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.L10 24H D22 BRD-K00384875 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.R10 24H D22 BRD-K00384875 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.R10 24H D24 BRD-K00384875 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.R10 24H D23 BRD-K00384875 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA009 XC.L10 24H D23 BRD-K00384875 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project